Loading clinical trials...
Loading clinical trials...
This is an academic, no-profit, multicenter, biological, non-pharmacologic study aimed at characterizing genome, transcriptome and proteome of patients affected by AML with MECOM or atypical 3q26 rear...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
NCT06313437 · Acute Myeloid Leukemia, AML, Adult, and more
NCT06704152 · AML, Adult Recurrent, ALL, Recurrent, Adult, and more
NCT06022003 · AML, Adult, Refractory AML, and more
NCT06420063 · AML, Acute Myeloid Leukemia, and more
NCT06486350 · AML, Adult
Ematologia
Piacenza
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions